Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Exploiting Interdata Relationships in Next-generation Proteomics Analysis.

Vitrinel B, Koh HWL, Mujgan Kar F, Maity S, Rendleman J, Choi H, Vogel C.

Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S5-S14. doi: 10.1074/mcp.MR118.001246. Epub 2019 May 24. Review.


Integration of large-scale multi-omic datasets: a protein-centric view.

Rendleman J, Choi H, Vogel C.

Curr Opin Syst Biol. 2018 Oct;11:74-81. doi: 10.1016/j.coisb.2018.09.001. Epub 2018 Sep 8.


New insights into the cellular temporal response to proteostatic stress.

Rendleman J, Cheng Z, Maity S, Kastelic N, Munschauer M, Allgoewer K, Teo G, Zhang YBM, Lei A, Parker B, Landthaler M, Freeberg L, Kuersten S, Choi H, Vogel C.

Elife. 2018 Oct 12;7. pii: e39054. doi: 10.7554/eLife.39054.


Time-course proteomics dataset monitoring HeLa cells subjected to DTT induced endoplasmic reticulum stress.

Cheng Z, Rendleman J, Vogel C.

Data Brief. 2016 Jul 26;8:1168-72. doi: 10.1016/j.dib.2016.07.038. eCollection 2016 Sep.


Genetic markers of pigmentation are novel risk loci for uveal melanoma.

Ferguson R, Vogelsang M, Ucisik-Akkaya E, Rai K, Pilarski R, Martinez CN, Rendleman J, Kazlow E, Nagdimov K, Osman I, Klein RJ, Davidorf FH, Cebulla CM, Abdel-Rahman MH, Kirchhoff T.

Sci Rep. 2016 Aug 8;6:31191. doi: 10.1038/srep31191.


The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Vogelsang M, Martinez CN, Rendleman J, Bapodra A, Malecek K, Romanchuk A, Kazlow E, Shapiro RL, Berman RS, Krogsgaard M, Osman I, Kirchhoff T.

Clin Cancer Res. 2016 Jul 1;22(13):3268-80. doi: 10.1158/1078-0432.CCR-15-2066. Epub 2016 Jan 5.


Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology.

Clendenen TV, Rendleman J, Ge W, Koenig KL, Wirgin I, Currie D, Shore RE, Kirchhoff T, Zeleniuch-Jacquotte A.

PLoS One. 2015 Aug 14;10(8):e0135943. doi: 10.1371/journal.pone.0135943. eCollection 2015.


Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.

Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Krogsgaard M, Kirchhoff T.

J Med Genet. 2015 Apr;52(4):231-9. doi: 10.1136/jmedgenet-2014-102832. Epub 2015 Jan 20.


Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.

Rendleman J, Antipin Y, Reva B, Adaniel C, Przybylo JA, Dutra-Clarke A, Hansen N, Heguy A, Huberman K, Borsu L, Paltiel O, Ben-Yehuda D, Brown JR, Freedman AS, Sander C, Zelenetz A, Klein RJ, Shao Y, Lacher M, Vijai J, Offit K, Kirchhoff T.

PLoS One. 2014 Jul 10;9(7):e101685. doi: 10.1371/journal.pone.0101685. eCollection 2014.


Melanoma risk loci as determinants of melanoma recurrence and survival.

Rendleman J, Shang S, Dominianni C, Shields JF, Scanlon P, Adaniel C, Desrichard A, Ma M, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Kirchhoff T.

J Transl Med. 2013 Nov 4;11:279. doi: 10.1186/1479-5876-11-279.


The crystal structure of the alpha-cellobiose.2 NaI.2 H(2)O complex in the context of related structures and conformational analysis.

Peralta-Inga Z, Johnson GP, Dowd MK, Rendleman JA, Stevens ED, French AD.

Carbohydr Res. 2002 Apr 30;337(9):851-61.


Hydrolytic action of alpha-amylase on high-amylose starch of low molecular mass.

Rendleman JA Jr.

Biotechnol Appl Biochem. 2000 Jun;31(3):171-8.


Conversion of cyclodextrin into high-amylose starch of low molecular mass by means of cyclodextrin glucanotransferase.

Rendleman JA Jr, Knutson CA Jr.

Biotechnol Appl Biochem. 1998 Dec;28 ( Pt 3):219-28.


Enhancement of cyclodextrin production through use of debranching enzymes.

Rendleman JA Jr.

Biotechnol Appl Biochem. 1997 Aug;26(1):51-61.


Supplemental Content

Loading ...
Support Center